These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 88084)

  • 1. [Immunosuppression in organ transplantation (author's transl)].
    Montandon A
    Ther Umsch; 1979 May; 36(5):418-25. PubMed ID: 88084
    [No Abstract]   [Full Text] [Related]  

  • 2. A single center experience with "low-dose" cyclosporine in cadaveric renal transplantation.
    Fries D; Hiesse C; Charpentier B; Lantz O; Bensadoun H; Benoit G
    Clin Transpl; 1988; ():115-29. PubMed ID: 3154465
    [No Abstract]   [Full Text] [Related]  

  • 3. [4-way immunosuppression in pre-sensitized recipients of allogenic cadaver kidney transplants].
    Oesterwitz H; May G; Müller P; Strobelt V; Seeger W; Seibt F; Horlbeck R; Hansen C
    Z Urol Nephrol; 1990 Jan; 83(1):1-8. PubMed ID: 2184625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cadaver kidney transplantation: a retrospective comparison of two immunosuppressive regimens.
    Dandavino R; Barcelo R; Beaudry C; Cardinal J; Carriere S; Friborg J; Houde M; Ouimet D; Bastien E; Girard R; Laplante L
    Transplant Proc; 1982 Dec; 14(4):635-9. PubMed ID: 6762720
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunosuppressive drugs used in clinical renal transplantation.
    Chatterjee SN
    Urology; 1977 Jun; 9(6 Suppl):52-60. PubMed ID: 70101
    [No Abstract]   [Full Text] [Related]  

  • 6. Quadruple drug therapy prevents graft loss from acute rejection without increasing mortality.
    Light JA; Aquino A; Ali A; Rodriguez R; Ali S
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1927-30. PubMed ID: 3547897
    [No Abstract]   [Full Text] [Related]  

  • 7. Early and late effects of two immunosuppressive drug protocols on recipients of renal allografts: results of the Minnesota randomized trial comparing cyclosporine versus antilymphocyte globulin-azathioprine.
    Canafax DM; Simmons RL; Sutherland DE; Fryd DS; Strand MH; Ascher NL; Payne WD; Najarian JS
    Transplant Proc; 1986 Apr; 18(2 Suppl 1):192-6. PubMed ID: 3515687
    [No Abstract]   [Full Text] [Related]  

  • 8. [Enzyme profiles observed after heart transplantations].
    Schwartz K; Clauvel de Mendonca M
    Ann Biol Clin (Paris); 1969; 27(7):461-86. PubMed ID: 4187678
    [No Abstract]   [Full Text] [Related]  

  • 9. Sequential conventional immunotherapy with maintenance cyclosporine following renal transplantation.
    Sommer BG; Henry ML; Ferguson RM
    Transplant Proc; 1986 Apr; 18(2 Suppl 1):69-75. PubMed ID: 3515698
    [No Abstract]   [Full Text] [Related]  

  • 10. [Experiences with plasmapheresis in the treatment of vascular rejection following kidney transplantation].
    Eismann R; Konert J; Langkopf B
    Z Urol Nephrol; 1990 Jan; 83(1):9-12. PubMed ID: 2330764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Failure of 125I-tracer selective monoclonal antibody levels on a whole blood matrix to predict rejection or nephrotoxic episodes in renal transplant patients under anti-lymphocyte globulin and prednisone therapy.
    Stiller C; Keown P
    Transplant Proc; 1990 Jun; 22(3):1253-4. PubMed ID: 2349687
    [No Abstract]   [Full Text] [Related]  

  • 12. Five years' experience with quadruple sequential immunosuppression.
    Fischbach M; Wolff P; Tongio MM; Boudjema K; Christmann D; Steib A; Sauvage P; Desprez P; Mengus L; Simeoni U
    Transplant Proc; 1994 Feb; 26(1):17. PubMed ID: 8108924
    [No Abstract]   [Full Text] [Related]  

  • 13. Control of rejection of transplanted organs.
    Keown PA; Stiller CR
    Adv Intern Med; 1986; 31():17-46. PubMed ID: 3511616
    [No Abstract]   [Full Text] [Related]  

  • 14. [Preventive administration of antithymocyte globulin in combined immunosuppressive therapy with cyclosporin A, azathioprine and prednisone in kidney transplantation].
    Matl I; Kaslíková J; Jirka J
    Cas Lek Cesk; 1991 Mar; 130(12):364-6. PubMed ID: 2032265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical experience with antilymphocyte globulin (ALG) in renal transplantation.
    Deodhar SD; Konomi K; Nakamoto S; Kuruvila KC
    Transplant Proc; 1971 Mar; 3(1):758-61. PubMed ID: 4937968
    [No Abstract]   [Full Text] [Related]  

  • 16. Quadruple immunosuppressive therapy for liver transplantation.
    Kalayoglu M; Stratta RJ; Hoffmann RM; Sollinger HW; Belzer FO
    Transplant Proc; 1988 Feb; 20(1 Suppl 1):524-9. PubMed ID: 3279646
    [No Abstract]   [Full Text] [Related]  

  • 17. Reversal of acute clinical and experimental organ rejection using large doses of intravenous prednisolone.
    Bell PR; Briggs JD; Calman KC; Paton AM; Wood RF; Macpherson SG; Kyle K
    Lancet; 1971 May; 1(7705):876-80. PubMed ID: 4102025
    [No Abstract]   [Full Text] [Related]  

  • 18. Is sequential low-dose immunotherapy the preferred treatment in cadaveric renal transplantation?
    Posner MP; Mendez-Picon G; King A; Nelson KP; Spicer HG; Lee HM
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1594-7. PubMed ID: 2652519
    [No Abstract]   [Full Text] [Related]  

  • 19. Low-dose ciclosporin, prednisone, and azathioprine after initial immunosuppression with ciclosporin and prednisone in a pediatric renal transplant population.
    Turner MC
    Child Nephrol Urol; 1990; 10(3):125-30. PubMed ID: 2285916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prednisone used as treatment for rejection correlates with poor outcome.
    Toussaint RM; Callender CO; Dunston GM; Flores J; Walters CS; John D; Yeager C; Bond O; Thompson C; Gear JC
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1712-5. PubMed ID: 2652561
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.